FRONTAL FIBROSING ALOPECIA

Clinical trials for FRONTAL FIBROSING ALOPECIA explained in plain language.

Never miss a new study

Get alerted when new FRONTAL FIBROSING ALOPECIA trials appear

Sign up with your email to follow new studies for FRONTAL FIBROSING ALOPECIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 2 Not yet finished but already full! 1

New drug trial targets scarring hair loss in women

Disease control Ongoing

This study is testing whether the drug baricitinib is safe and effective for treating frontal fibrosing alopecia (FFA), a condition that causes permanent hair loss and scarring. The trial will involve 15 adult women with active FFA who will take the medication to see if it reduce…

Matched conditions: FRONTAL FIBROSING ALOPECIA

Phase: PHASE4 • Sponsor: University of Alabama at Birmingham • Aim: Disease control

Last updated Apr 04, 2026 08:05 UTC

FRONTAL FIBROSING ALOPECIA

Get alerted when new FRONTAL FIBROSING ALOPECIA trials appear

New drug trial targets scarring hair loss in women